MolecuLight

Toronto, Canada Founded: 2013 • Age: 13 yrs
Point-of-care devices for wound bacterial assessment are provided.
Annual revenue - Latest available
Total funding $43.2M 6 rounds
Employees 49 Tracked headcount
Investors 8 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About MolecuLight

MolecuLight is a company based in Toronto (Canada) founded in 2013. MolecuLight has raised $43.2 million across 6 funding rounds from investors including Hayfin, Prosegur and Oxford Finance. The company has 49 employees as of May 27, 2025. MolecuLight operates in a competitive market with competitors including Kent Imaging, ARANZ Medical, Eykona Technologies, WoundVision and CutoSense, among others.

  • Headquarter Toronto, Canada
  • Employees 49 as on 27 May, 2025
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Moleculight Corp.
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $43.2 M (USD)

    in 6 rounds

  • Latest Funding Round
    $27.5 M (USD), Series D

    Jan 06, 2025

  • Investors
    Hayfin

    & 7 more

  • Employee Count
    49

    as on May 27, 2025

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of MolecuLight

Headcount 10-50
Employee Profiles 12
Employee Profiles
People
Anil Amlani
CEO at MolecuLight Inc
People
Greg Duncan
Regional Sales Manager
People
Danielle Dunham
Director Of Marketing And Product Management
People
Jeffrey Kirman
Director of Advanced Development

Unlock access to complete

Funding Insights of MolecuLight

MolecuLight has successfully raised a total of $43.2M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $27.5 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in MolecuLight

MolecuLight has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Hayfin, Prosegur and Oxford Finance.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private debt investments are directed across multiple sectors.
Locked Locked Locked
-
Locked Locked Locked
Healthcare-focused venture capital is provided by iGan Partners.
Locked Locked Locked
Premium access

Investor details for MolecuLight

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by MolecuLight

Investments
Premium access

Investment portfolio details for MolecuLight

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - MolecuLight

Premium access

Detailed financials for MolecuLight

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Moleculight Comparisons

MolecuLight Primary company
Description
Point-of-care devices for wound bacterial assessment are pro...
Location
Toronto, Canada
Founded Year
2013
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
49
As of 2025
Premium access

Peer comparison for MolecuLight

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of MolecuLight

MolecuLight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kent Imaging, ARANZ Medical, Eykona Technologies, WoundVision and CutoSense, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Near-infrared imaging solutions for wound care are provided.
Locked Locked Locked
3D scanning systems for wound care and orthotics are developed.
Locked Locked Locked
Portable 3D imaging systems for dermatological applications are provided.
Locked Locked Locked
Provides wound imaging software for accurate measurement and medical documentation.
Locked Locked Locked
Medical systems for wound treatment are developed and analyzed.
Premium access

Detailed competitors of MolecuLight

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Moleculight

Premium access

Complete news archive for MolecuLight

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MolecuLight

MolecuLight was founded in 2013 and raised its 1st funding round 1 year after it was founded.

MolecuLight is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

MolecuLight is a funded company, having raised a total of $43.2M across 6 funding rounds to date.

As of May 27, 2025, the latest employee count at MolecuLight is 49.

MolecuLight was founded in 2013 in Toronto, Canada, as a provider of medical devices in the wound care sector. A handheld fluorescence imaging device, known as i:X, is offered for visualizing bacterial presence and distribution in skin and chronic wounds. The product was launched in 2015, enabling point-of-care assessment in clinical settings. Operations focus on fluorescence-based diagnostics for improved wound management.

MolecuLight's top competitors include CutoSense, Kent Imaging and ARANZ Medical.

MolecuLight has 8 investors. Key investors include Hayfin, Prosegur, Oxford Finance, SWK Holdings, and BDC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available